These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38527490)

  • 1. Rationalising Optimal Dosing of Phytotherapeutics For Use In Children: Current Status - Potential Solutions - Actions Needed.
    Hensel A; Bauer R; Heinrich M; Hempel G; Kelber O; Kraft K; Lehmann B; Medà MM; Nieber K; Roether B; Rollinger JM; Wiebelitz R
    Planta Med; 2024 May; 90(6):416-425. PubMed ID: 38527490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States.
    Qu L; Zou W; Wang Y; Wang M
    Phytomedicine; 2018 Mar; 42():219-225. PubMed ID: 29655689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Market access for Chinese herbal medicinal products in Europe-A ten-year review of relevant products, policies, and challenges.
    Xiong Y; Li M; Sun P; Liang W; Hornbeck RG; Che X; Rao C; Zhao Y; Guo L; Huang Y; Yang H; Li P; Kroes BH; Cui X; Franz G; Wang M
    Phytomedicine; 2022 Aug; 103():154237. PubMed ID: 35688101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
    Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
    J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities and hurdles to European market access for multi-herbal traditional Chinese medicine products: An analysis of EU regulations for combination herbal medicinal products.
    Qu L; Li X; Xiong Y; Wang Z; Zhou Y; Zou W; Tang J; Wang M
    Pharmacol Res; 2022 Dec; 186():106528. PubMed ID: 36332812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of genotoxicity of herbal medicinal products: a co-ordinated approach.
    Kelber O; Steinhoff B; Kraft K;
    Phytomedicine; 2012 Mar; 19(5):472-6. PubMed ID: 22301069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of medicinal plants for public health--European community monographs on herbal substances.
    Knöss W; Chinou I
    Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monographs, list entries, public statements.
    Chinou I
    J Ethnopharmacol; 2014 Dec; 158 Pt B():458-62. PubMed ID: 25193681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal medicinal products in the paediatric population--status quo and perspectives.
    Wegener T
    Wien Med Wochenschr; 2013 Feb; 163(3-4):46-51. PubMed ID: 23377951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of herbal medicines in Brazil.
    Carvalho AC; Ramalho LS; Marques RF; Perfeito JP
    J Ethnopharmacol; 2014 Dec; 158 Pt B():503-6. PubMed ID: 25169216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug safety aspects of herbal medicinal products.
    Wegener T; Deitelhoff B; Silber-Mankowsky A
    Wien Med Wochenschr; 2015 Jun; 165(11-12):243-50. PubMed ID: 26183727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnoveterinary contemporary knowledge of farmers in pre-alpine and alpine regions of the Swiss cantons of Bern and Lucerne compared to ancient and recent literature - Is there a tradition?
    Stucki K; Cero MD; Vogl CR; Ivemeyer S; Meier B; Maeschli A; Hamburger M; Walkenhorst M
    J Ethnopharmacol; 2019 Apr; 234():225-244. PubMed ID: 30572090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, patterns and beliefs about the use of herbal medicinal products in Ghana: a multi-centre community-based cross-sectional study.
    Kretchy IA; Koduah A; Opuni KFM; Agyabeng K; Ohene-Agyei T; Boafo EA; Ntow PO
    Trop Med Int Health; 2021 Apr; 26(4):410-420. PubMed ID: 33350035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of genotoxicity of herbal medicinal products: application of the "bracketing and matrixing" concept using the example of Valerianae radix (valerian root).
    Kelber O; Wegener T; Steinhoff B; Staiger C; Wiesner J; Knöss W; Kraft K
    Phytomedicine; 2014; 21(8-9):1124-9. PubMed ID: 24837473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality Requirements for Medicinal Cannabis and Respective Products in the European Union - Status Quo.
    Veit M
    Planta Med; 2023 Jul; 89(8):808-823. PubMed ID: 35338476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal medicinal products - Evidence and tradition from a historical perspective.
    Jütte R; Heinrich M; Helmstädter A; Langhorst J; Meng G; Niebling W; Pommerening T; Trampisch HJ
    J Ethnopharmacol; 2017 Jul; 207():220-225. PubMed ID: 28668645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks associated with herbal medicinal products.
    Ernst E; Pittler MH
    Wien Med Wochenschr; 2002; 152(7-8):183-9. PubMed ID: 12017745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TradReg 2013: regulation of herbal and traditional medicinal products--European and global strategies--international symposium.
    Cranz H; Anquez-Traxler C
    J Ethnopharmacol; 2014 Dec; 158 Pt B():495-7. PubMed ID: 25281419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional herbal medicines worldwide, from reappraisal to assessment in Europe.
    van Galen E
    J Ethnopharmacol; 2014 Dec; 158 Pt B():498-502. PubMed ID: 25043781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.